Neurophysiological Changes Associated with Antidepressant Response to Ketamine Not Observed in a Negative Trial of Scopolamine in Major Depressive Disorder

BACKGROUND: This randomized, placebo-controlled, crossover trial examined the antidepressant efficacy of the muscarinic antagonist scopolamine in major depressive disorder subjects with more severe and refractory forms of major depressive disorder relative to previous reports. METHODS: Participants...

Täydet tiedot

Tallennettuna:
Bibliografiset tiedot
Julkaisussa:Int J Neuropsychopharmacol
Päätekijät: Park, Lawrence, Furey, Maura, Nugent, Allison C, Farmer, Cristan, Ellis, Jessica, Szczepanik, Joanna, Lener, Marc S, Zarate, Carlos A
Aineistotyyppi: Artigo
Kieli:Inglês
Julkaistu: Oxford University Press 2018
Aiheet:
Regular Research Articles
Linkit:https://ncbi.nlm.nih.gov/pmc/articles/PMC6313153/
https://ncbi.nlm.nih.gov/pubmed/30184133
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/ijnp/pyy051
Tagit: Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!

Samankaltaisia teoksia